TransMedics (Nasdaq:TMDX) received FDA investigational device exemption (IDE) for its next-generation OCS ENHANCE Heart trial.
VALLEY FORGE, PA — Vanguard recently announced sweeping cost cuts across its investment lineup, lowering expense ratios on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results